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Key questions
What is already known about this subject?
 ► Infertility and need for in vitro fertilisation (IVF) have 
never been examined in patients with atrial septal 
defect (ASD).
 ► Indeed, no studies have examined the extent of in-
fertility and IVF in any patients with congenital heart 
disease.
What does this study add?
 ► In this nationwide study, we show that women with 
ASDs have an increased risk of receiving IVF when 
compared with a reference cohort (HR 3.14, 95% CI 
2.1 to 4.7, p<0.0001).
 ► Furthermore, we discovered that 3 times as many 
women with ASD needed IVF when compared with 
the reference cohort.
 ► We also confirmed that women with ASD experience 
pre- eclampsia more frequently during pregnancy.
How might this impact on clinical practice?
 ► Our results present important information for health-
care professionals providing pregnancy counselling 
for women with ASD trying to conceive.
 ► Awareness of issues with infertility and increased 
risk of IVF might increase the chance of a pregnancy.
AbstrAct
Objective To investigate in vitro fertilisation (IVF) in 
women with atrial septal defect (ASD), and to examine the 
maternal characteristics and outcome of pregnancy, as 
well as the fetal outcome of infants born by women with 
ASD.
Methods We used population- based registries in this 
nationwide cohort study, including Danish individuals born 
before 1994 who received an ASD diagnosis between 
1959 and 2014. Patients were compared with a random 
reference sample (ratio of 10 citizens per patient) matched 
by sex and age. The Danish Medical Birth Register (DMBR) 
contains data on all pregnancies and births in Denmark 
from 1977 to present. Risk of IVF treatment as well as 
maternal, pregnancy and fetal outcomes were compared.
Results A total of 2277 Danish patients had a validated 
ASD diagnosis. Of these, 310 women were identified in the 
DMBR. Women with ASD had an increased risk of receiving 
IVF treatment (HR 3.14, 95% CI 2.1 to 4.7, p<0.0001), 
and a higher proportion of patients received IVF treatment 
when compared with the reference cohort (10.6% vs 
3.2%; p<0.001). Furthermore, patients had more multiple 
births. Looking at singleton pregnancies (n=519), pre- 
eclampsia occurred more frequently in patients with ASD 
during pregnancy (6.7% vs 2.3%; p<0.001). Infants from 
mothers with ASD were found to have perinatal outcomes 
comparable to those of infants from the reference group.
Conclusion Women with ASD had an increased risk 
of and received more IVF treatment than the reference 
group. The outcome of pregnancy in these patients were 
generally uneventful, however, we did confirm that pre- 
eclampsia occurred more frequently.
BaCkgROund
Improvement in the management of patients 
with congenital heart disease (CHD) over 
the last decades has been considerable and, 
subsequently, the majority of these patients 
now live well into their childbearing age.1 2
Atrial septal defect (ASD) is one of the most 
frequent CHDs also in pregnant women. 
Pregnancy is associated with additional 
volume loading producing a circulatory 
burden that, consequently, aggravates the 
right ventricular volume overload caused by 
defect.3 Many unanswered questions remain 
regarding women with ASD and pregnancy, 
as issues with infertility and need for in vitro 
fertilisation (IVF) have never been addressed. 
Indeed, no studies have, to our knowledge, 
examined the extent of infertility and IVF in 
any patients with CHD, and only few studies 
have investigated the outcome of pregnancy 
in women with ASDs.4–7
Given that most women with ASD reach 
the fertile age and contemplate pregnancy, 
healthcare professionals have a difficult task 
of providing counsel for women trying to 
conceive. In this study, we investigate if the 
need for IVF treatment is higher among 
women with ASD, as well as the associated 
infertility diagnosis, using the unique Danish 
registries and comparing outcome with the 
general population. In addition, we examined 
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both the maternal characteristics and outcome of preg-
nancy in mothers with ASD, as well as the fetal outcome 
of infants born by women with ASD.
MetHOds
study population
We used several medical registries in this nationwide 
descriptive cohort study. All registered Danish residents 
are automatically entitled to publicly financed healthcare 
with equal accessibility for all Danes. Mandatory registra-
tion of data from all hospitals and outpatient clinics is 
collected in numerous nationwide public registries. We 
used the Danish National Patient Registry (DNPR) to 
identify all patients diagnosed with an ASD between 1977 
and 2017, as this register contains complete and contin-
uously updated data on all Danish residents since its 
beginning in 1977. To ensure follow- up into adulthood, 
patients had to be born before 1994. The DNPR has data 
on all inpatient hospital contacts in Denmark, dates of 
contact and discharge, surgical procedures and discharge 
diagnoses coded according to the International Classifi-
cation of Disease (ICD).8 The 8th edition was used until 
1993 and was subsequently replaced by the 10th edition. 
The ASD diagnosis was validated by two independent 
physicians through review of hospital records. Patients 
with concomitant CHD or persisting foramen ovale were 
excluded. This cohort has been described in a previous 
study investigating mortality in patients with ASD.9 We 
used the Danish Civil Registration System to draw a 
random reference sample matched by sex and age with 
the included patients with ASD, resulting in a ratio of 10 
citizens per patient.
The unique personal identification number, assigned 
to each Danish citizen at birth since 1968, was used to 
link patients diagnosed with an ASD to another Danish 
registry: The Danish Medical Birth Register (DMBR).10 11 
This register contains data on all pregnancies and births 
in Denmark from 1977 to present. Thus, our study popu-
lation consisted of women with an ASD diagnosis, regis-
tered in the DNPR, present in the DMBR.
IVF and infertility diagnoses
Fertility treatment is free of charge in Danish public 
clinics, offering three to six intrauterine insemination 
treatment cycles and three IVF cycles. We identified IVF 
treatment in the DNPR by the codes BJFL00 and BJFL00A. 
Proportions of IVF treatment were reported for both the 
entire ASD study population (both men and women), 
and for the identified mothers with ASD in the DMBR. 
Subgroups of infertility diagnoses were also identified in 
the DNPR by the codes DN97 to DN979 with additional 
codes DN80 to DN809 for endometriosis, and DE282 for 
polycystic ovary syndrome (PCOS). Codes for all variables 
are provided in online supplementary table 1.
Pregnancy and fetal outcome
We used the DMBR to obtain information about both 
maternal, pregnancy and fetal characteristics. All 
reported measurements and recordings are performed by 
highly trained healthcare professionals, and registration 
immediately after birth has been mandatory in Denmark 
since 1977.11 It should be noted that gestational age at 
birth after 1997 has been based on ultrasound measure-
ments in >93% of cases, and that early cord clamping was 
used nationwide when the DMBR was initiated. Lastly, the 
untrimmed placenta was weighed in the delivery room by 
using a digital scale.
statistics
Continuous, normally distributed data were reported 
as mean±SD. The unpaired Student’s t- test was used for 
normally distributed data. Categorical variables were 
summarised by percentages or frequencies. Comparisons 
of categorical maternal, pregnancy and fetal character-
istics between patients and the general population were 
performed by Fisher’s exact test. Cox proportional regres-
sion analysis was used to compute HRs for IVF treatment 
in patients with ASD comparing them with the reference 
cohort. Analyses were adjusted for smoking, parental age 
and parity. Statistical significances were defined as a p 
value <0.05. Missing data were found in body mass index 
(BMI), height and smoking, as these variables were not 
systematically implemented in the registries from the 
beginning of registration. Missing was dropped from the 
analyses, and values are presented in the relevant tables. 
All analyses were performed using Stata IC V.15.1 (Stat-
aCorp, College Station, Texas, USA).
Results
study population
A total of 4445 patients born before 1994 and diagnosed 
with an ASD before 2013 were identified in the DNPR. We 
excluded 609 patients due to concomitant CHD. Further 
651 patients were excluded as their hospital record was 
missing, thereby leaving 3185 patients for validation. 
Lastly, we excluded patients with a persisting foramen 
ovale or no ASD, providing a final total of 2220 patients 
with a confirmed ASD diagnosis. Additionally, a matched 
comparison cohort of 22 565 were included. Of the 2220 
identified patients, 310 female patients (mean age 29.9 
years) were present in the DMBR. We identified 3677 
females in the reference group. Maternal characteristics 
for both groups are summarised in table 1.
No differences in age, smoking, prepregnancy BMI 
or number of previous miscarriages were found when 
comparing patients with the reference group.
IVF treatment and births
The prevalence of IVF treatment in the entire ASD 
cohort (n=2220) was significantly higher when compared 
with the general population (1.9% vs 0.8%; p<0.001). 
Looking at the DMBR, mothers with ASD (n=310) had a 
total of 559 births, of which 40 births (7.2%) were multi-
ples (table 1). In comparison, the 3677 female references 
gave birth 6580 times with significantly fewer (3.7%; 
p=0.001) being of multiples. A significant increase in IVF 
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Table 1 Maternal characteristics (patients with ASD 
compared with the general population)
Variable
Mothers 
with ASD 
n=310
References 
n=3677 P value
Maternal age, years 
(mean±SD)
29.9±5.0 29.9±4.9 0.902
Maternal prepregnancy BMI, 
kg/m2*
(mean±SD)
24.1±4.7 24.6±8.2 0.242
Height, cm*
(mean±SD)
168.9±50.8 166.3±24.1 0.092
Smoker, n (%)† 60 (21.5) 661 (19.7) 0.705
Paternal age, years
(mean±SD)
33.0±6.1 32.3±5.6 0.007
Births, n 559 6580 –
Singleton birth, n 519 6324 –
Multiple birth, n 40 256 –
Multiple birth, % 7.2% 3.9% 0.001
IVF treatment, n (%) 33 (10.6) 119 (3.2) <0.001
Maternal age at IVF 
treatment, years
(mean±SD) (range)
29.6±0.90
(21.3–40.1)
30.8±0.36
(20.8–41.4)
–
Multiple pregnancy following 
IVF, n (%)
8 (20.0) 24 (9.4) 0.055
Previous miscarriage, n (%) 54 (17.4) 602 (16.4) 0.753
*Data were missing for BMI and height in 139 mothers with ASD 
and 1487 references.
†Data were missing for smoking in 32 mothers with ASD and 
336 references.
ASD, atrial septal defect ; BMI, body mass index; IVF, in vitro 
fertilisation.
Table 2 Infertility diagnoses among mothers with ASD and 
general population receiving IVF treatment
Variable
ASD 
mothers 
receiving 
IVF n=33
References 
receiving IVF 
n=119 P value
Endometriosis, n (%) 2 (6.1) 8 (6.7) 0.100
Polycystic ovary 
syndrome, n (%)
0 (0) 5 (4.2) 0.586
Anovulation, n (%) 2 (6.5) 7 (5.9) 1.000
Tubal factor, n (%) 2 (6.1) 18 (15.9) 0.247
Uterine factor, n (%) 1 (3) 2 (1.7) 0.523
Male factor, n (%) 4 (12.1) 18 (15.3) 0.786
Other causes, n (%) 29 (87.9) 99 (83.2) 0.601
Patients might have more than one diagnosis.
ASD, atrial septal defect ; IVF, in vitro fertilisation.
treatment was evident when comparing female patients 
with ASD (10.6%) with women from the general popu-
lation (3.2%; p<0.001). The risk of receiving IVF treat-
ment was increased in patients with ASD compared with 
the reference group (adjusted HR 3.14, 95% CI 2.1 to 
4.7, p<0.0001). The distribution of infertility diagnoses 
among patients and references who received IVF treat-
ment did not differ between the two groups (table 2).
Outcome of pregnancy
We found 519 singletons pregnancies in the group of 
women with an ASD, and 6324 singleton pregnancies in 
the reference group. All singleton pregnancy outcome 
data are presented in table 3.
A significantly higher proportion of patients with ASD 
experienced pre- eclampsia during their pregnancy when 
compared with the general population. Correspond-
ingly, patients with ASD also had more visits to specialists. 
Other pregnancy complications including preterm prela-
bour rupture of membranes, polyhydramnios, placenta 
accreta and placental abruption did not differ between 
patients with ASD and the general population.
Fetal characteristics
Generally, infants born by mothers with ASD displayed 
similar fetal characteristics as infants in the general popu-
lation (table 4).
Birth weight was found to be slightly, however signifi-
cantly, lower in infants from mothers with ASD when 
compared with the general population (3466.4±585.7 g vs 
3524.3±586.4 g; p=0.032). Variables such as lengths, head 
circumference and waist circumference did not differ 
between the two groups.
dIsCussIOn
This is the first study to investigate IVF and infertility 
diagnoses in any CHD, and the first nationwide study to 
examine pregnancy and fetal outcome in mothers with 
ASD. Our cohort study showed that women with an ASD 
diagnosis had an increased risk and a higher prevalence 
of IVF treatment, and also had more multiple births. 
Additionally, it confirmed that pre- eclampsia occurred 
more frequently in patients with ASD during pregnancy. 
Infants from mothers with ASD were found to have peri-
natal outcomes comparable to those of infants from the 
general population despite a slightly lower birth weight.
A substantial proportion of women with ASDs needed 
help to conceive, a number well above the need found in 
the reference cohort. Whereas the increased number of 
multiple births among women with ASD is likely explained 
by the increased levels of IVF, our data do not provide an 
explanation for the IVF usage itself. In this regard, it can 
only be speculated if patients with a an ASD diagnosis who 
experience difficulties conceiving would be referred to 
IVF treatment at an earlier stage than patients without a 
diagnosis, or if this outcome may reasonably be attributed 
to the late consequences of the haemodynamic effects of 
the ASD. Despite being a common clinical problem, and 
an issue that might be concerning to many women, most 
questions regarding infertility and fertility treatment in 
patients with CHD remain unanswered. Indeed, these 
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Table 3 Pregnancy- related outcome in all single pregnancies among female patients with ASD compared with the general 
population
Variable
Single pregnancies patients 
with ASD n=519
Single pregnancies 
references n=6324 P value
Gestational age, days
(mean±SD)
277.5±13.4 278.7±13.1 0.048
Midwife visits, n 5.0 4.9 0.444
Physicians visits, n 3 3 0.135
Specialists visits, n (min- max) 2 (0–9) 1 (0–9) <0.001
PPROM, n (%) 24 (4.6) 270 (4.3) 0.653
Placenta previa, n (%) 3 (0.6) 25 (0.04) 0.001
Placental weight, g
(mean±SD)
635.3±215.7 651.5±180.3 0.055
Polyhydramnios, n (%) 4 (0.8) 39 (0.6) 0.565
Pre- eclampsia, n (%) 35 (6.7) 142 (2.3) <0.001
Sectio, n (%) 114 (22.0) 1160 (18.3) 0.046
Sectio mothers wish, n (%) 13 (2.5) 107 (1.7) 0.165
Placenta accreta, n (%) 5 (1) 41 (0.7) 0.394
Hemoperitoneum, n (%) 2 (0.4) 17 (0.3) 0.651
Intrauterine asphyxia, n (%) 4 (0.8) 66 (1) 0.819
Placental abruption, n (%) 6 (1.1) 36 (0.6) 0.131
Gestational age was slightly lower in the patients with ASD (277.5±13.4 vs 278.7±13.1; p=0.048).
ASD, atrial septal defect ; PPROM, preterm prelabour rupture of membranes.
Table 4 Fetal outcome in all single pregnancies among 
female patients with ASD compared with the general 
population
Variable
Singletons 
from 
mothers 
with ASD 
n=519
Singletons 
from 
reference 
mothers 
b=6324 P value
Length at birth, g
(mean±SD)
51.5±6.0 51.6±4.9 0.494
Birth weight, g
(mean±SD)
3466.4±585.7 3524.3±586.4 0.032
Head circumference, 
cm
(mean±SD)
34.3±6.4 34.4±5.0 0.472
Waist circumference, 
cm
(mean±SD)
32±7.0 32±6.7 0.935
Stillborn, n 2 18 0.661
Sepsis, n (%) 5 (1) 92 (1.5) 0.444
ASD, atrial septal defect .
aspects and outcome hereof are only described in a few 
subtypes of congenital lesions and in small study samples. 
In women with the Fontan circulation, the outcome of 
pregnancy showed increased risk of miscarriage, preterm 
birth and poor fetal growth.12 In contrast, other studies 
on women with Tetralogy of Fallot and Ebstein’s anomaly 
showed that the fertility in these patients was not affected, 
perhaps suggesting that infertility issues may be related 
to specific lesions and, therefore, affects the CHD popu-
lation differently. However, the small sample sizes found 
in both studies might undermine their reliability as both 
hold a significant risk of being underpowered. Whether 
our findings are related to differentiated algorithms for 
referral to IVF treatment, alternated haemodynamics 
or simple genetics is not known, and, consequently, 
the pathophysiological basis of this unexpected finding 
deserves further investigation.
The increased prevalence of pre- eclampsia in women 
with ASD has been described previously in smaller cohorts 
from Dutch and Belgian registries, reporting almost 
identical results as ours. Interestingly, similar findings 
have been found in healthy women with children with 
ASD.13 14 Indeed, ASDs in children were strongly asso-
ciated with maternal early preterm pre- eclampsia (OR 
12.0, 95% CI 8.96 to 16.1) and late perm pre- eclampsia.13 
These associations indicate that the same pathophysiolog-
ical mechanisms might be involved in the pathogenesis in 
both pre- eclampsia and ASD. Several studies have already 
suggested angiogenetic imbalance as a key component 
contributing to the pathogenesis in both congenital 
heart defects in general and preterm pre- eclampsia.15–17 
While speculative, abnormal heart development could 
be caused by an angiogenetic imbalance in the fetus with 
ensuring anti- angiogenesis at the trophoblast stage, and a 
maternal anti- angiogenic state might cause the following 
cascade of events: reduced trophoblast invasion of the 
spiral arteries, hypoxia in the placenta, hypoxia in the 
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fetus, overproduction of anti- angiogenic factors in the 
fetus and abnormal heart formation. No matter what the 
cause, the strong associations demonstrated between pre- 
eclampsia and ASD lends further support to the notion 
that there are unforeseen challenges to having an ASD 
that cannot be explained by the contemporary haemody-
namic effects.
Finally, it has been suggested that reduced placental 
perfusion may cause pre- eclampsia, however, we do not 
expect diminished cardiac output and, subsequently, 
reduced blood flow through the placenta in women with 
ASD.18
Given the adverse events, including higher rates of 
IVF treatment and a higher prevalence of pre- eclampsia 
during pregnancy, it was reassuring that fetal outcome 
in offspring of women with ASDs were comparable to 
the reference cohort. Nonetheless, our findings did 
suggest that the birth weight in these infants is lower than 
normal. This is in accordance with the findings by Yap 
et al, demonstrating significantly lower birth weight and 
higher risk of being small for gestational age in offspring 
of mothers with ASDs.7 Interestingly, these results were 
associated with the corrective status of the defect, as only 
offspring of women with an unrepaired ASD experienced 
these adverse outcomes. This association adds to the 
conclusion of a novel study characterising the natural 
history of unrepaired ASD, describing how a defect ‘that 
is considered insignificant and not warranting closure in 
early life cannot be considered to be a benign lesion’.19 
The demonstrated fetal outcome also reflects that of 
infants born with ASD from healthy parents, as lower 
birth weight, normal head circumference and normal 
placental weight have been demonstrated in these 
infants.20 21
limitations
Our data did not suggest an explanation for the higher 
usage of IVF treatment among women with ASD. 
Whether higher awareness among obstetricians when 
confronted with a mother with a CHD, including ASD, 
results in earlier referral for IVF treatment is unknown. 
Additionally, it is unknown if any ASDs were diagnosed 
during the workup prior to IVF treatment, causing an 
over- representation.
We did not address the potential effects of social skew-
ness. People from lower social groups conceive earlier, 
and recent unpublished studies show a higher propor-
tion of patients with ASD in these social groups. It might 
be that patients with ASD try to conceive at a younger 
age, thereby, identifying fertility issues earlier than an 
age- matched reference group and, consequently, receive 
IVF treatment at a younger age.
Finally, interpreting register- based data inherently has 
some limitations as the validity of the diagnoses in the 
registries depend of the physicians generating the data. 
However, all ASD diagnoses given in the DNPR had been 
manually validated leaving very little error for potential 
misreporting and under- reporting or over- reporting.22 23 
Diagnoses for IVF treatment and infertility have not been 
formally validated, but some diagnoses such as PCOS 
appear to be substantially under- reported in the DNPR.
COnClusIOn
In this nationwide study, women with ASD had an 
increased risk and a higher prevalence of IVF treatment, 
and more multiple births. The outcome of pregnancy in 
these patients were generally uneventful, however, we did 
confirm that pre- eclampsia occurred more frequently, 
perhaps suggesting similar pathophysiological mecha-
nisms. Despite the increased risk for needing IVF treat-
ment and greater risk of pre- eclampsia, the fetal outcome 
was, reassuringly, comparable to the healthy background 
population. Our results highlight a new area of interest 
for future research, as fertility treatment and infertility 
need to be investigated throughout the spectrum of CHD.
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